Status:
COMPLETED
Risk Factors for Progressive Supranuclear Palsy (PSP)
Lead Sponsor:
University of Louisville
Collaborating Sponsors:
National Institute on Aging (NIA)
Conditions:
Progressive Supranuclear Palsy
Eligibility:
All Genders
40+ years
Brief Summary
Progressive supranuclear palsy (PSP) is the most common atypical parkinsonian movement disorder. This study will determine the role of specific genetic, occupational and environmental components in th...
Detailed Description
This proposal will determine: (1) if there is an association between PSP and specific genes of interest; (2) if there is an association between PSP and occupational and/or environmental chemical expos...
Eligibility Criteria
Inclusion
- PSP patients able to visit one of the screening sites for diagnostic confirmation and able to participate in a one hour telephone interview
Exclusion
- No other major neurological disorders
- Unable to communicate by telephone
Key Trial Info
Start Date :
August 1 2006
Trial Type :
OBSERVATIONAL
Allocation :
ACTUAL
End Date :
June 1 2013
Estimated Enrollment :
942 Patients enrolled
Trial Details
Trial ID
NCT00431301
Start Date
August 1 2006
End Date
June 1 2013
Last Update
April 10 2017
Active Locations (10)
Enter a location and click search to find clinical trials sorted by distance.
1
University of Alabama, Birmingham
Birmingham, Alabama, United States, 35233
2
UCLA
Los Angeles, California, United States, 90095-1759
3
University of Colorado
Aurora, Colorado, United States, 80045
4
Emory College of Medicine
Atlanta, Georgia, United States, 30322